Top Markets
Coin of the day
AVAX Technologies, Inc. AVAX Technologies, Inc.

AVAX Technologies, Inc.

AVXT
Rankning i aktier #41955
AVAX Technologies, Inc. is an emerging biopharmaceutical company focused on... AVAX Technologies, Inc. is an emerging biopharmaceutical company focused on pioneering autologous cell vaccine methods for cancer therapy. Its pipeline includes lead candidates M-VAX, for melanoma, and O-VAX, targeting ovarian cancer, both of which have successfully concluded Phase II clinical trials. The firm is also developing LungVax, a potential treatment for non-small cell lung cancer. Established in 1990, the Philadelphia, Pennsylvania-based entity initially operated as Walden Laboratories, Inc. before adopting its current name, AVAX Technologies, Inc., in March 1996.
Aktiekurs
$0.00001
Senast synkroniserad: 2025-12-30
Marknadsvärde
$6.89K
Förändring (1 dag)
0.00%
Förändring (1 år)
0.00%
Land
US
Handel AVAX Technologies, Inc. (AVXT)

Kategori

Aktiekurshistorik för AVAX Technologies, Inc. (AVXT)
Högsta slutkurs: $0.00 den 2025-12-01

Lägsta slutkurs: $5.70 den 1997-05-01
Aktiekurshistorik för AVAX Technologies, Inc. från 1997 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) 0.00%
2025 0.00%
2024 -90.00%
2023 0.00%
2022 -29.03%
2021 -92.02%
2020 29.21%
2019 62.70%
2018 -57.93%
2017 -45.69%
2016 -85.27%
2015 184.66%
2014 150.18%
2013 -39.36%
2012 -82.52%
2011 -23.65%
2010 -61.01%
2009 671.71%
2008 -87.28%
2007 -15.34%
2006 -53.45%
2005 27.11%
2004 26.14%
2003 -8.09%
2002 -67.56%
2001 -85.17%
2000 -25.37%
1999 125.74%
1998 -36.11%
1997 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$527.87 33.33%
US
$873.57 35.10%
NL
$736.38 7.69%
CH
$1.08K -6.44%
KR
$263.09 18.09%
BE